Susann Wichmann1, Clemens Kirschbaum2, Carsten Böhme3, Katja Petrowski4. 1. Department of Psychology and Psychotherapy, University Witten/Herdecke, Germany. Electronic address: Susann.Wichmann@uni-wh.de. 2. Department of Psychology, Institute of Biological Psychology, Technische Universität Dresden, Germany. 3. Department of Psychotherapy and Psychosomatic Medicine, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany. 4. Department of Psychology and Psychotherapy, University Witten/Herdecke, Germany; Department of Psychotherapy and Psychosomatic Medicine, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.
Abstract
BACKGROUND: Previous research has focussed extensively on the distinction of HPA-axis functioning between patient groups and healthy volunteers, with relatively little emphasis on a direct comparison of patient groups. The current study's aim was to analyse differences in the cortisol stress response as a function of primary diagnosis of panic disorder (PD), post-traumatic stress disorder (PTSD), and major depressive disorder (MDD). METHODS: A total of n=30 PD (mean age±SD: 36.07±12.56), n=23 PTSD (41.22±10.17), n=18 MDD patients (39.00±14.93) and n=47 healthy control (HC) individuals (35.51±13.15) participated in this study. All the study participants were female. The Trier Social Stress Test (TSST) was used for reliable laboratory stress induction. Blood sampling accompanied the TSST for cortisol and ACTH assessment. Panic-related, PTSD-specific questionnaires and the Beck Depression Inventory II were handed out for the characterisation of the study groups. Repeated measure ANCOVAs were conducted to test for main effects of time or group and for interaction effects. Regression analyses were conducted to take comorbid depression into account. RESULTS: 26.7% of the PD patients, 43.5% of the PTSD patients, 72.2% of the MDD patients and 80.6% of the HC participants showed a cortisol stress response upon the TSST. ANCOVA revealed a cortisol hypo-responsiveness both in PD and PTSD patients, while no significant group differences were seen in the ACTH concentrations. Additional analyses showed no impact of comorbid depressiveness on the cortisol stress response. MDD patients did not differ in the hormonal stress response neither compared to the HC participants nor to the PD and PTSD patients. CONCLUSION: Our main findings provide evidence of a dissociation between the cortisol and ACTH concentrations in response to the TSST in PTSD and in PD patients, independent of comorbid depression. Our results further support overall research findings of a cortisol hypo-responsiveness in PD patients. A hypo-response pattern was also seen in the PTSD patients agreeing with previous finding on the cortisol stress reactivity following TSST stress induction in these patients. Patients with a primary MDD diagnosis showed descriptively higher cortisol concentrations compared to the anxiety patients, and lower cortisol concentrations as the healthy individuals. The limitations of the study and implications for future studies will be discussed.
BACKGROUND: Previous research has focussed extensively on the distinction of HPA-axis functioning between patient groups and healthy volunteers, with relatively little emphasis on a direct comparison of patient groups. The current study's aim was to analyse differences in the cortisol stress response as a function of primary diagnosis of panic disorder (PD), post-traumatic stress disorder (PTSD), and major depressive disorder (MDD). METHODS: A total of n=30 PD (mean age±SD: 36.07±12.56), n=23 PTSD (41.22±10.17), n=18 MDDpatients (39.00±14.93) and n=47 healthy control (HC) individuals (35.51±13.15) participated in this study. All the study participants were female. The Trier Social Stress Test (TSST) was used for reliable laboratory stress induction. Blood sampling accompanied the TSST for cortisol and ACTH assessment. Panic-related, PTSD-specific questionnaires and the Beck Depression Inventory II were handed out for the characterisation of the study groups. Repeated measure ANCOVAs were conducted to test for main effects of time or group and for interaction effects. Regression analyses were conducted to take comorbid depression into account. RESULTS: 26.7% of the PDpatients, 43.5% of the PTSDpatients, 72.2% of the MDDpatients and 80.6% of the HC participants showed a cortisol stress response upon the TSST. ANCOVA revealed a cortisol hypo-responsiveness both in PD and PTSDpatients, while no significant group differences were seen in the ACTH concentrations. Additional analyses showed no impact of comorbid depressiveness on the cortisol stress response. MDDpatients did not differ in the hormonal stress response neither compared to the HC participants nor to the PD and PTSDpatients. CONCLUSION: Our main findings provide evidence of a dissociation between the cortisol and ACTH concentrations in response to the TSST in PTSD and in PDpatients, independent of comorbid depression. Our results further support overall research findings of a cortisol hypo-responsiveness in PDpatients. A hypo-response pattern was also seen in the PTSDpatients agreeing with previous finding on the cortisol stress reactivity following TSST stress induction in these patients. Patients with a primary MDD diagnosis showed descriptively higher cortisol concentrations compared to the anxietypatients, and lower cortisol concentrations as the healthy individuals. The limitations of the study and implications for future studies will be discussed.
Authors: Stefanie E Mayer; Melissa Peckins; Kate R Kuhlman; Nirmala Rajaram; Nestor L Lopez-Duran; Elizabeth A Young; James L Abelson Journal: Psychoneuroendocrinology Date: 2020-06-17 Impact factor: 4.905
Authors: Marilyn N Vera-Chang; Antony D St-Jacques; Rémi Gagné; Chris J Martyniuk; Carole L Yauk; Thomas W Moon; Vance L Trudeau Journal: Proc Natl Acad Sci U S A Date: 2018-12-10 Impact factor: 11.205
Authors: Matthew C Morris; Brooklynn Bailey; Natalie Hellman; Amber Williams; Edward W Lannon; Matthew E Kutcher; Julie A Schumacher; Uma Rao Journal: Psychoneuroendocrinology Date: 2020-10-06 Impact factor: 4.905
Authors: Amanda K Gilmore; Constance Guille; Nathaniel L Baker; Kathleen T Brady; Christine K Hahn; Callah M Davis; Jenna L McCauley; Sudie E Back Journal: Addict Behav Date: 2019-01-05 Impact factor: 3.913
Authors: Amanda K Gilmore; Christine K Hahn; Anna E Jaffe; Kate Walsh; Angela D Moreland; Erin F Ward-Ciesielski Journal: Addict Behav Date: 2018-05-31 Impact factor: 3.913
Authors: Andres D Roque; Michelle G Craske; Michael Treanor; David Rosenfield; Thomas Ritz; Alicia E Meuret Journal: Psychoneuroendocrinology Date: 2020-03-07 Impact factor: 4.905